ライフサイエンスコーパス: PVP

1 PVP and CVP were found to be highly correlated (r=0.947)

2 PVP and EHV neurons were insensitive to active head move

3 PVP and intracardiac pressures were obtained by transduc

4 PVP can act as a capping and etching agent for protectio

5 PVP can be performed safely and effectively with conscio

6 PVP neurons were less sensitive to on-direction head mov

7 PVP was performed in 50 patients with metastatic disease

8 PVP's high affinity for water and the nifedipine-polymer

9 PVP-AgNPs and AgNO3 both affected pathways involved in N

10 PVP-AgNPs have the potential to cause effects both throu

11 PVP-AuNPs can be a powerful absorber to influence the em

12 PVP-free colloids were also prepared but less stable tha

13 PVP-I is a safe antiseptic and does not appear to impede

14 PVP-stabilized NPs in a 10-fold diluted OECD media (chlo

15 PVP/GSNO formulations at doses of 25 and/or 100, but not

16 inylpyrrolidone (molecular weight, 360,000) (PVP-360), was found to increase the sensitivity as well

17 ridyl poly(vinylpyridine) chloride [Os(bpy)2(PVP)10Cl](+) films assembled layer-by-layer with polyion

18 -oxodG) is selectively oxidized by [Os(bpy)2(PVP)10Cl](+) in intact ds-DNA to provide catalytic squar

19 electroluminescent (ECL) polymer ([Ru(bpy)(2)PVP(10)](2+)) were extended to include a fully represent

20 Films containing [Os(bpy)(2)(PVP)(10)Cl](+) and [Ru(bpy)(2)(PVP)(10)Cl](+) metallopol

21 g [Os(bpy)(2)(PVP)(10)Cl](+) and [Ru(bpy)(2)(PVP)(10)Cl](+) metallopolymers were assembled layer by l

22 films of poly(4-vinylpyridine)-Ru(bpy)2(2+) [PVP-Ru(bpy)2(2+), bpy = 2,2'-bipyridine] on pyrolytic gr

23 In2 O3 :5%PVP-based transistors exhibit mobilities approaching 11

24 ter, in batch reactors spiked with 5 x 10(6) PVP-nAg particles/mL (10 mug/L), an environmentally rele

25 At a PVP concentration of 100 g/L, the data are consistent wi

26 The presence of a PVP coating on CuNPs has little effect on inhibition.

27 linear polyacrylamide, and PVP showed that a PVP-, PA-, or FC-coated capillary, in combination with H

28 After PVP in 26 (52%) patients, there was a period of increase

29 t of change in pain level and activity after PVP.

30 New vertebral fractures after PVP were clustered within patients and depended heavily

31 Except for Ag-PVP, the affinity of NPs for porous medium, indicated by

32 lidone (PVP) surface ligands and nonideal Ag-PVP-Ag contact at NW-NW junctions.

33 s (NPs) coated with polyvinylpyrrolidone (Ag-PVP) and stabilized by citrate (Ag-CIT) in biofilm-laden

34 Uncharged PVP stabilized Ag-PVP by steric repulsion, and the attachment to glass bea

35 of aqu-nC60, fullerol, and Ag-CIT; while Ag-PVP was again sterically stabilized.

36 ty tests indicate that AgNP-citrate and AgNP-PVP did not exhibit toxicity to the amphipod (Ampelisca

37 r nanoparticles (NPs) (AgNP-citrate and AgNP-PVP) in marine organisms via marine sediment exposure wa

38 virens (N. virens) in the AgNP-citrate, AgNP-PVP and a conventional salt (AgNO3) treatments.

39 ne sediments amended with AgNP-citrate, AgNP-PVP, and AgNO3 was AgCl (50-65%) > Ag2S (32-42%) > Ag me

40 zed), (3) polyvinylpyrrolidone coated AgNPs (PVP-AgNPs) (sterically stabilized), and (4) branched pol

41 AgNO3 and PVP-AgNP exposed fish had common and distinct effects co

42 o common organic capping agents (citrate and PVP) were evaluated.

43 p exposure biomarkers for citrate-coated and PVP-coated AgNPs.

44 METHODS AND PVP-HF (Peripheral Venous Pressure Measurements in Patie

45 ol subjects; (2) overall, PEG, parylene, and PVP produced less histologic disruption than the other t

46 rite induces the degradation of both PES and PVP.

47 lcellulose (HEC), linear polyacrylamide, and PVP showed that a PVP-, PA-, or FC-coated capillary, in

48 A combination of PPP and PVP imaging is sufficient for detection of pancreatic ad

49 ed that tumor conspicuity during the PPP and PVP was equivalent but superior to that during the AP.

50 a attenuation differences during the PPP and PVP were equivalent but greater than that during the AP.

51 e stress markers when compared to saline and PVP groups.

52 on of cediranib in polyvinylpyrrolidone (AZD/PVP) from these devices were achieved.

53 The water-soluble AZD/PVP, which exhibited similar bioactivity as cediranib, w

54 Patients were evaluated before PVP and at 3, 6 and 12 months post-PVP, both 'off' and '

55 etween PVP and CVP was 0.4 mm Hg and between PVP and pulmonary capillary wedge pressure was 7.5 mm Hg

56 The mean difference between PVP and CVP was 0.4 mm Hg and between PVP and pulmonary

57 The presence of both PVP and Na(2)S facilitate the formation of nanocubes.

58 des effective magnetic actuation, while both PVP and iron oxide have low toxicity.

59 nylboronic acid and iodobenzene catalyzed by PVP-Pd nanoparticles to investigate the effect of cataly

60 In vivo effects were supported by PVP-AgNP activation of five in vitro nuclear receptor as

61 s beads) and nanoparticle surface chemistry (PVP, citrate, or humic acid) on alpha, and found a stron

62 chloride) beads and beads made from chitosan/PVP (polyvinylpyrrolidone) blend, which resulted in 85.2

63 oated PVC beads and on the beads of chitosan/PVP blend, respectively.

64 In this study, monodisperse citrate, PVP, and PEG coated AgNPs with a core size of approximat

65 cted protocols: the in-house methods of CTAB-PVP (cetyltrimethylammonium bromide-polyvinylpyrrolidone

66 sed samples were produced by using different PVP chain lengths.

67 network originating from rapidly dissolving PVP plays a key role.

68 As elevated PVP is associated with liver failure after living donor

69 The addition of excess PVP stabilizer to the reaction mixture seems to lead to

70 Moreover, excessive PVP interconnect and form PVP-based hydrogels, which lat

71 Following PVP removal, biotinylated thiol and streptavidin protein

72 be 140 and 30 repeating units per nm(2) for PVP of 55,000 and 10,000 g/mol in molecular weight, resp

73 ecies will be harmed ranged from <1 ug/L for PVP-coated n-Ag to >3.5 mg/L for CNTs.

74 )-free nanostars compared with 98 nm/RIU for PVP-coated gold nanostars.

75 oreover, excessive PVP interconnect and form PVP-based hydrogels, which later convert into conductive

76 Free PVP-SE1 phages in solution showed the ability to recogni

77 eedle used in this study was fabricated from PVP and methacrylic acid, using the lithography method.

78 gly, physical mixture containing furosemide, PVP K12 and SDS produced a similar level of oral exposur

79 andard ferri/ferrocyanide is achieved on a G/PVP/PANI-modified electrode with a 3-fold increase in th

80 The droplet-like nanostructures of G/PVP/PANI-modified electrodes are obtained with an averag

81 cholesterol oxidase (ChOx) is attached to G/PVP/PANI-modified electrode for the amperometric determi

82 ing network to render the resultant graphene-PVP thin film conductive, which varies in presence of hu

83 In the majority of European hospitals PVP-iodine-alcohol is still standard of care to prepare

84 We confirm that HPMA, PVP, PMOX, PDMA and PAcM modified liposome have increase

85 humidity due to swelling of the hygroscopic PVP host.

86 Ca(NO3)2 and showed no discernible change in PVP-nAg transport behavior in the presence of 1 to 100 m

87 erage density of PVP from the differences in PVP concentration and the total surface area of Ag nanoc

88 normal pancreas); 2) maximum enhancement in PVP that gradually decreases in DP (type 2 pattern: mild

89 le addresses the effects of povidone-iodine (PVP-I) and its utility in the treatment of periodontal d

90 ively concentrates iodine as a yellow iodine-PVP complex.

91 ol dimethacrylate and triallyl isocyanurate, PVP-DEGMA-TAIC; and poly(acrylamide-co-ethylene glycol-d

92 ransformation products resulting from 40 kDa PVP-coated silver nanoparticles (AgNPs) reacted in aerat

93 nhibitors increasing in effectiveness, PEO < PVP < PVCap < VIMA, have increasingly negative (exotherm

94 Median PVP was 9.5 (6-17) mm Hg, CVP was 8.5 (6-18) mm Hg, and

95 (poly[N-(2-hydroxypropyl) methacrylamide]), PVP (poly(vinylpyrrolidone)), PMOX (poly(2-methyl-2-oxaz

96 he PVP-Au seeds, produced by directly mixing PVP with HAuCl4, were able to catalyze H2O2 to enlarge A

97 the luminal membrane surface displayed more PVP than PS.

98 pyrrolidone)-stabilized silver nanoparticle (PVP-nAg) in columns packed with water-saturated quartz s

99 ylpyrrolidone)-protected gold nanoparticles (PVP-AuNPs) and fluorescent BSA-protected gold nanocluste

100 inylpyrrolidone-coated silver nanoparticles (PVP-AgNPs) cause effects through intact nanoparticles or

101 rrolidone (PVP) coated silver nanoparticles (PVP-AgNPs) on the composting of municipal solid waste.

102 The new PVP capped CoFe2O4@CdSe with core-shell nanostructure wa

103 The freeze-dried capsule, 10%w/w nifedipine/PVP, had the highest dissolution rate constant of 0.37 +

104 study clearly shows that small AgNPs (5 nm, PVP and Tan) dissolve rapidly and almost completely, whi

105 By adjusting the In2 O3 :PVP weight ratio, crystallization is frustrated, and con

106 Of these, the OCT-PVP combination was found to be most effective.

107 ptimal performance was observed with the OCT-PVP-coated capillary and HEC as the polymer network.

108 urface plasmon resonance (SPR) absorption of PVP-AuNPs and the excitation of BSA-AuNCs.

109 The SPR absorption of PVP-AuNPs was enhanced with an increased concentration o

110 The addition of PVP as hydrophilic modifier to polysulfone-based membran

111 essed, it was concluded that the addition of PVP in a PLGA matrix resulted in vivo in a more sustaine

112 microplate surface, whereas the addition of PVP-360 increased the sensitivity of antibody detection.

113 terestingly, the presence of small amount of PVP (2 mg mL(-1)) in the nanocomposites can substantiall

114 dy, we further illustrate the application of PVP for the interpretation of whole exome sequencing dat

115 rt failure syndromes, a simple assessment of PVP demonstrates a high correlation with CVP.

116 The benefits of PVP-I in the treatment of refractory periodontitis are u

117 ing also resulted in earlier breakthrough of PVP-nAg compared to younger biofilm coatings, or to the

118 ent shapes depending on the concentration of PVP in the solution.

119 to grow at a fixed initial concentration of PVP to find out when {111} facets started to appear on t

120 to grow at reduced initial concentrations of PVP to see at which concentration {111} facets started t

121 were used to determine the optimal cutoff of PVP and independent risk factors of PLF.

122 We could calculate the coverage density of PVP from the differences in PVP concentration and the to

123 We derived the coverage density of PVP on Ag(100) surface by combining the results from two

124 gNPs and Citrate-AgNPs but the deposition of PVP-AgNPs followed the same order of the electrostatical

125 developed for the environmental detection of PVP AgNPs; although further verification under different

126 characterize the bioaccumulation dynamics of PVP-, PEG-, and citrate-AgNPs, in comparison to dissolve

127 vity and amenability to functionalization of PVP-free gold nanostars should prove useful in applicati

128 N-H group of nifedipine and the C=O group of PVP was observed and this interaction inhibited nifedipi

129 , which received intragingival injections of PVP; saline; or PVP/GSNO solutions which corresponded to

130 o either 4.8 mug/L of AgNO3 or 61.4 mug/L of PVP-AgNPs for 96h.

131 ments) with an intraoperative measurement of PVP at the end of the procedure were included.

132 Intraoperative modulation of PVP would be advisable when PVP exceeds 20 mm Hg.

133 ability is caused by the polymeric nature of PVP and that the degree of stabilization depends on both

134 We demonstrate the performance of PVP in identifying causative variants on a large number

135 The presence of PVP and its molar ratio (in terms of repeating unit) rel

136 ices with opposite senses in the presence of PVP but the same sense in the presence of D-sorbitol.

137 The presence of PVP prevents interaction of the Pt nanoparticles with th

138 vide direct evidence for the preservation of PVP-coatings in the presence of Na2S and fulvic acid, wh

139 skin was attained by optimizing the ratio of PVP to methacrylic acid.

140 indicated significantly reduced retention of PVP-nAg at low IS compared to clean sand, irrespective o

141 The decreased retention of PVP-nAg in biofilm-coated sand compared to clean sand is

142 improved by 150-times compared with that of PVP-wrapped ones.

143 iated infections, suggesting that the use of PVP-iodine should be reevaluated for disinfection of the

144 the literature suggests that utilization of PVP-I is potentially beneficial in the management of som

145 also evaluated, which consisted of films of [PVP-Ru(bpy)2(2+)] on PG electrodes coated with films of

146 P in 25/25 patients (sensitivity = 100%), on PVP in 22/25 (sensitivity = 88%) and on DP in 20/25 (sen

147 in 31/38 patients (sensitivity = 81.6%), on PVP in 29/38 (sensitivity = 76.3%) and on DP in 17/38 (s

148 ence stability of these suspensions based on PVP morphological changes at different pH values.

149 do not cause an ABC effect such as, HPMA or PVP, deserve further consideration as polymer coatings t

150 days and was slower compared to pure PCL or PVP.

151 intragingival injections of PVP; saline; or PVP/GSNO solutions which corresponded to GSNO doses of 2

152 dation of 1-thioglycerol (TG) mediated by Os-PVP complex on the surface of graphite electrode at appl

153 polyvinylpyridine bearing osmium complex (Os-PVP).

154 odified with a conductive osmium polymer (Os-PVP) complex were employed to quantify resulting CdS QDs

155 after unilateral posteroventral pallidotomy (PVP).

156 (PV) neurons, 30 position-vestibular-pause (PVP) neurons and 9 eye-head-vestibular (EHV) neurons.

157 Release of antibiotic from PCL-PVP dosage forms was shown over 5 days and was slower co

158 of binding of four inhibitor molecules (PEO, PVP, PVCap, and VIMA) to a hydrate surface is estimated

159 with ultrafiltration and nanofiltration PES/PVP membranes for various aging times.

160 egarding the mechanism of degradation of PES/PVP membranes by sodium hypochlorite.

161 d by a rapid decline on portal venous phase (PVP) and delayed phase (DP) at 5 minutes (type 1 pattern

162 rterial phase (HAP) and portal venous phase (PVP).

163 chymal phase (PPP), and portal venous phase (PVP).

164 ding X 3Si-R-SiX 3 with poly(4-vinyl)phenol (PVP) require very low-curing temperatures ( approximatel

165 l to acquire a pulse volume plethysmography (PVP) waveform and calibrate it to brachial BP levels est

166 Solid dispersions, based on a PLGA/PVP matrix, were compared to solid dispersions in a pure

167 based on the structure of these binary PLGA/PVP matrices where the pore network originating from rap

168 prised of the commercially available polymer PVP = poly(4-vinylpyridine) and the Au(I) precursors [Au

169 dine)Os(bipyridyl)2Cl(2+/3+)] redox polymer (PVP-Os) through a layer-by-layer (LBL) self-assembly pro

170 coatings, citrate and polyvinylpirrolidone (PVP), and prepared nanoparticle suspensions (approximate

171 coatings, citrate and polyvinylpirrolidone (PVP), both showed strong interactions with ferbam and in

172 o separate 40 nm sized polyvinylpirrolidone (PVP)- and citrate-coated NPs, 40 nm sized polyethylene g

173 m arabic (GA-AgNPs) or polyvinylpyrollidone (PVP-AgNPs), as well as AgNO(3).

174 rd inorganic salts and polyvinylpyrrolidine (PVP(55000)) stabilizers.

175 we sample and analyze polyvinylpyrrolidone (PVP) and the IR spectrum measured by photothermal spectr

176 Dextran and polyvinylpyrrolidone (PVP) also vitrified but did not depress T(m) during dryi

177 nanoplates (NPLs) and polyvinylpyrrolidone (PVP) by using Au nanoparticles as concentration referenc

178 of gum arabic (GA) and polyvinylpyrrolidone (PVP) coated Ag nanoparticles (NPs) in aquatic microcosms

179 rmation of citrate and polyvinylpyrrolidone (PVP) coated silver nanoparticles (NPs) (AgNP-citrate and

180 f polysulfone (PS) and polyvinylpyrrolidone (PVP), were investigated, regarding chemical structure an

181 xicity of uncoated and polyvinylpyrrolidone (PVP)-coated CuO, and Cu2O nanoparticles, as well as Cu i

182 , gum arabic (GA), and polyvinylpyrrolidone (PVP).

183 were also considered: polyvinylpyrrolidone (PVP), tannic acid (Tan), and citric acid (Cit).

184 ons of GSNO-containing polyvinylpyrrolidone (PVP) formulations is evaluated in a rat model of periodo

185 ted to the ill-defined polyvinylpyrrolidone (PVP) surface ligands and nonideal Ag-PVP-Ag contact at N

186 0 nm) containing drug, polyvinylpyrrolidone (PVP) K12 and sodium dodecyl sulfate (SDS) in 1:2.75:0.25

187 the release of Ag from polyvinylpyrrolidone (PVP)- and citrate-coated 80 nm nAg in aerobic WW effluen

188 osite of graphene (G), polyvinylpyrrolidone (PVP) and polyaniline (PANI) has been successfully prepar

189 lymer concentration in polyvinylpyrrolidone (PVP) and Ficoll solutions of different molecular weights

190 ns and distribution of polyvinylpyrrolidone (PVP) and citrate (CT) coated AgNPs in boreal lake mesoco

191 the multiple roles of polyvinylpyrrolidone (PVP) and their dependence on other factors.

192 valuates the impact of polyvinylpyrrolidone (PVP) coated silver nanoparticles (PVP-AgNPs) on the comp

193 at aim, suspensions of polyvinylpyrrolidone (PVP)-coated ceria nanoparticles (NPs) were produced.

194 y(ether sulfone) (PES)/polyvinylpyrrolidone (PVP) membranes are widely used in various industrial fie

195 LGA) and water-soluble polyvinylpyrrolidone (PVP) was evaluated.

196 nts (tannic acid (TA), polyvinylpyrrolidone (PVP), branched polyethylenimine (BPEI), polyethylene gly

197 of 474 nm/RIU for the polyvinylpyrrolidone (PVP)-free nanostars compared with 98 nm/RIU for PVP-coat

198 fter disinfection with polyvinylpyrrolidone (PVP or povidone)-iodine-alcohol and the correlation with

199 or citrate- (cit) and polyvinylpyrrolidone- (PVP) capped silver nanoparticles (AgNPs), in the presenc

200 ne glycols (PEGs), or polyvinylpyrrolidones (PVPs) of various molecular weights to pulmonary surfacta

201 u and Ag stabilized by polyvynylpyrrolidone (PVP).

202 safety was evaluated with review of all post-PVP complications and their treatment.

203 bles significantly improved at 3 months post-PVP (P = -0.013) and this improvement was maintained at

204 improvement was maintained at 12 months post-PVP (P = 0.012-0.041).

205 maximum improvement is seen at 3 months post-PVP with many variables remaining significantly improved

206 ed before PVP and at 3, 6 and 12 months post-PVP, both 'off' and 'on' parkinsonian medications, with

207 the improvement maintained at 12 months post-PVP.

208 were significantly improved at 3 months post-PVP.

209 ing significantly improved at 12 months post-PVP.

210 mutagenesis to the S4-S5 linker and the post-PVP S6 segment, and conducted electrophysiological analy

211 Posthepatectomy PVP is an independent predictive factor of PLF and of 90

212 Posthepatectomy PVP was gradually correlated with the PLF risk.

213 At multivariate analysis, posthepatectomy PVP remained an independent predictor of PLF as well as

214 tectomy may be influenced by posthepatectomy PVP.

215 The optimal value of posthepatectomy PVP to predict PLF was 22 mm Hg when considering the "50

216 ) of 50 patients reported improvement in pre-PVP pain.

217 emonstrate the PhenomeNET Variant Predictor (PVP) system that exploits semantic technologies and auto

218 ificantly reduced both portal vein pressure (PVP) and HVR (P=0.04).

219 were unchanged, peripheral venous pressure (PVP) increased (P < 0.05), MSNA total activity decreased

220 ought to compare peripheral venous pressure (PVP) with central venous pressure (CVP), as well as othe

221 Portal venous pressure (PVP), IHR, plasma and hepatic levels of various substanc

222 in the conserved Kv proline-valine-proline (PVP) motif, Cd(2+) forms intrasubunit coordination with

223 polymer (polystyrene-b-polyvinylpyridine, PS-PVP) and a hydrogen-bonding agent (HA) enables formation

224 lycaprolactone (PCL), polyvinyl pyrrolidone (PVP) and their composite system (PVP-PCL).

225 l alcohol (IPA) using polyvinyl pyrrolidone (PVP) polymer as the stabilizer.

226 ained with the aid of polyvinyl pyrrolidone (PVP).

227 in the presence of poly(vinyl pyrrolidone) (PVP) and a trace amount of Fe(3+) or Fe(2+).

228 in the presence of poly(vinyl pyrrolidone) (PVP) and a trace amount of Na(2)S.

229 ectly mixed 20% w/v poly(vinyl pyrrolidone) (PVP) gel, with the mixture filled into laser engineered

230 in the presence of poly(vinyl pyrrolidone) (PVP) has recently been demonstrated as a convenient meth

231 bon (AC), parylene, poly(vinyl pyrrolidone) (PVP), or poly(ethylene glycol) (PEG) were each implanted

232 trate (Na(3)CA) and poly(vinyl pyrrolidone) (PVP), respectively, as a capping agent while all other p

233 with biocompatible poly(vinyl pyrrolidone) (PVP), which can be polymerized in situ to entrap the SWN

234 in the presence of poly(vinyl pyrrolidone) (PVP).

235 ter treatment plant (WWTP) that had received PVP coated 50 nm Ag NPs and 30 nm ZnO NPs, dissolved met

236 a system comprising poly(vinylpyrrolidone)s (PVPs) of varying molecular weights as crowding agents an

237 edral seeds themselves, both having the same PVP capping agent.

238 EG)- and citrate-coated NPs, and 60 nm sized PVP- and citrate-coated NPs.

239 sized citrate-coated and 40 and 60 nm sized PVP-coated NPs, could be distinguished.

240 nt-derived DOM had the effect of stabilizing PVP-AgNPs as primary particles, but caused GA-AgNPs to b

241 re data to support the following statements: PVP-I is a potent antiseptic and, when used as a compone

242 In a typical synthesis, PVP-stabilized Au-Cu nanoparticle aggregates synthesized

243 yrrolidone (PVP) and their composite system (PVP-PCL).

244 reased circulation times in rodents and that PVP, PDMA, and PAcM do not induce the ABC effect.

245 Our data provide clear evidence that PVP-iodine-alcohol is effective for preparation of the p

246 We find that PVP accurately identifies causative variants in whole ex

247 We also observed that PVP- and Tan-AgNPs are more prone to Ag(+) release than

248 The results suggest that PVP K12 and SDS were able to increase the furosemide fre

249 These findings suggest that PVP may be useful in the standard bedside clinical asses

250 The PVP layer provides a high density of proton-accepting py

251 The PVP was also found to be partly released from the membra

252 The PVP-AgNPs breakthrough occurred more rapid as compared t

253 The PVP-Au seeds, produced by directly mixing PVP with HAuCl

254 t during the HAP (-25.3%, P < .0001) and the PVP (-22.4%, P < .0001) in all patients.

255 ual residue in the protein structure and the PVP concentration.

256 o repulsive electrosteric forces between the PVP coatings and extracellular polymeric substances (EPS

257 DNA damage repair genes were induced by the PVP AgNPs, but not the other treatments.

258 ring the HAP or of 50% or greater during the PVP.

259 ximal venous enhancement was seen during the PVP.

260 ired method was then employed to extract the PVP waveform from the same waveform via ensemble averagi

261 However, removal of the PVP with UV light results in a 50-fold enhancement in th

262 ally, the slope of the rising portion of the PVP-nAg breakthrough curve was noticeably steeper in bio

263 ) treatment process to thoroughly remove the PVP ligands and produce a clean Ag-Ag interface that all

264 were also prepared but less stable than the PVP-protected NPs.

265 l characterization studies indicate that the PVP-nAg is stable in suspension and exhibits little chan

266 CPB film quality is correlated with the PVP-cross-linking reagent reactivity.

267 ock-triggered proton transfer from phenol to PVP.

268 for citrate-coated nanoparticles relative to PVP-coated nanoparticles.

269 Uncharged PVP stabilized Ag-PVP by steric repulsion, and the attac

270 A total of 115 patients who underwent PVP for 216 painful long-standing OVCFs were prospective

271 Unilateral PVP improves axial symptoms of Parkinson's disease invol

272 Patches prepared using PVP and TE-HCL displayed enhanced hydrophobicity.

273 ate of SSIs of 4.04% was achieved when using PVP-iodine-alcohol for disinfection of the preoperative

274 enced by the weight ratio of NMP and 20% w/v PVP.

275 doping In2 O3 films with poly(vinylphenole) (PVP).

276 s in combination with poly(vinylprrolidone) (PVP) and polyacrylamide (PA) as the polymeric coat.

277 icrobeads coated with poly(2-vinylpyridine) (PVP).

278 In blends with poly(4-vinylpyridine) (PVP) and phenol, NR showed an excess shock-induced red-s

279 diators are made of a poly(4-vinylpyridine) (PVP) polymer with Os complexes tethered to the polymer b

280 hin thin shells of poly(N-vinylpyrrolidone) (PVP), which leads to significantly improved protein stab

281 on using sulfur and poly(vinylpyrrolidone) (PVP) as catalytic promoters carried out in the author's

282 f the role played by poly(vinylpyrrolidone) (PVP) in seed-mediated growth of Ag nanocrystals.

283 of additives such as poly(vinylpyrrolidone) (PVP) or D-sorbitol, form ring-banded spherulites compose

284 gradation within the poly(vinylpyrrolidone) (PVP) polymer matrix.

285 ions of the cosolute poly(vinylpyrrolidone) (PVP) that mimic the protein concentration in cells.

286 is impregnated with poly(vinylpyrrolidone) (PVP), which exhaustively concentrates iodine as a yellow

287 ulated in a layer of poly(vinylpyrrolidone) (PVP).

288 ons for all but the highest-molecular-weight PVP can be described in detail by Newtonian hydrodynamic

289 nian effects in the highest-molecular-weight PVP solution.

290 n PVP was 20 mm Hg, and from 24% to 33% when PVP was 30 mm Hg.

291 ve modulation of PVP would be advisable when PVP exceeds 20 mm Hg.

292 % to 16%, depending on PLF definitions, when PVP was 20 mm Hg, and from 24% to 33% when PVP was 30 mm

293 Probability for PLF was nil when PVP was 10 mm Hg or less, ranges from 13% to 16%, depend

294 While PVP-AgNPs were quite stable and resisted transformation

295 und to be highly correlated (r=0.947), while PVP and pulmonary capillary wedge pressure were found to

296 he influence of the two capping agents, with PVP-AgNPs showing few or no significant changes in appar

297 The 90-day mortality was associated with PVP greater than 21 mm Hg, older than 70 years, and intr

298 al counts were taken after disinfection with PVP-iodine-alcohol, immediately before incision.

299 ose oxidase (GOx), electrically "wired" with PVP-[Os(N,N'-dimethyl-2,2'-biimidazole)(3)](2+/3+) (poly

300 done), Wizard with and without RNase, Wizard-PVP with and without RNase, and the Wizard Magnetic and